Total planned funding: $126,408,686
Allocations
Countries/Regions
India | $126,408,686 |
Organizational Types
Unknown | $58,486,962 |
NGO | $29,500,064 |
Own Agency | $19,892,171 |
University | $8,240,217 |
Private Contractor | $3,339,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $1,550,000 |
Host Country Government Agency | $1,200,000 |
FBO | $1,100,000 |
Program Areas
Governance and Systems | $52,418,907 |
Prevention | $29,766,616 |
Care | $16,038,435 |
Management and Operations | $15,771,211 |
Testing | $6,466,666 |
Treatment | $5,946,851 |
Budget Codes
OHSS: Health Systems Strengthening | $32,004,636 |
HVSI: Strategic Information | $16,859,066 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,292,987 |
HVMS: Management and Operations | $15,771,211 |
HBHC: Care: Adult Care and Support | $9,932,537 |
HVCT: Testing: HIV Testing and Counseling | $6,466,666 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,042,436 |
HTXS: Treatment: Adult Treatment | $5,566,580 |
HKID: Care: Orphans and Vulnerable Children | $3,880,071 |
HLAB: Laboratory Infrastructure | $3,555,205 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,402,379 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,988,573 |
HVTB: Care: TB/HIV | $1,965,810 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $356,794 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$58,486,962
Countries/Regions
USG Aggregated Agencies:
$13,899,272
Countries/Regions
FHI 360:
$11,992,311
Countries/Regions
Voluntary Health Services:
$5,260,000
Countries/Regions